SAN DIEGO, May 20, 2021 — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic, mitochondrial diseases, today reported financial results for the quarter ended March 31, 2021 and provided an update on its clinical programs. Key Operational Highlights Initiated the… Continue reading Reneo Pharmaceuticals Reports First Quarter 2021 Financial Results
